Pasar al contenido principal

ESTUDIO MULTIDISCIPLINAR DE LA OBSTRUCCION MICROVASCULAR Y SU REPARACION TRAS UN INFARTO AGUDO DEMIOCARDIO: DE LA ARTERIA CORONARIA A LA MICROCIRCULACION. FOCO EN EL FACTOR VEGF-A165B

PI17/01836

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2017
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION HOSPITAL CLINICO UNIVERSITARIO DE VALENCIA
Centro realización INSTITUTO DE INVESTIGACION SANITARIA INCLIVA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Magnetic resonance microscopy and correlative histopathology of the infarcted heart

  • Perez-Terol, Itziar
  • Rios-Navarro, César
  • de Dios, Elena
  • Morales, José Manuel|||0000-0002-4404-6735
  • Gavara Doñate, Jose|||0000-0002-3483-7066
  • Perez-Sole, Nerea
  • Diaz, Ana
  • Minana, Gema
  • Segura-Sabater, Remedios
  • Bonanad, Clara
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Husser, Oliver
  • Monmeneu, José V.
  • Lopez-Lereu, María P.
  • Núñez, Julio|||0000-0003-1672-7119
  • Chorro, Francisco J.
  • Ruiz-Sauri, Amparo
  • Bodi, Vicente|||0000-0001-6425-5828
  • Monleon, Daniel|||0000-0002-4803-1573
Delayed enhancement cardiovascular magnetic resonance (MR) is the gold-standard for non-invasive assessment after myocardial infarction (MI). MR microscopy (MRM) provides a level of detail comparable to the macro objective of light microscopy. We used MRM and correlative histopathology to identify infarct and remote tissue in contrast agent-free multi-sequence MRM in swine MI hearts. One control group (n = 3 swine) and two experimental MI groups were formed: 90 min of ischemia followed by 1 week (acute MI = 6 swine) or 1 month (chronic MI = 5 swine) reperfusion. Representative samples of each heart were analysed by contrast agent-free multi-sequence (T1-weighting, T2-weighting, T2*-weighting, T2-mapping, and T2*-mapping). MRM was performed in a 14-Tesla vertical axis imager (Bruker-AVANCE 600 system). Images from MRM and the corresponding histopathological stained samples revealed differences in signal intensities between infarct and remote areas in both MI groups (p-value < 0.001). The multivariable models allowed us to precisely classify regions of interest (acute MI: specificity 92% and sensitivity 80%; chronic MI: specificity 100% and sensitivity 98%). Probabilistic maps based on MRM images clearly delineated the infarcted regions. As a proof of concept, these results illustrate the potential of MRM with correlative histopathology as a platform for exploring novel contrast agent-free MR biomarkers after MI.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome

  • Gabaldon-Perez, Ana|||0000-0002-2475-0282
  • Marcos Garcés, Víctor|||0000-0001-5565-5547
  • Gavara Doñate, Jose|||0000-0002-3483-7066
  • Rios-Navarro, Cesar|||0000-0002-6405-6279
  • Miñana, Gema|||0000-0001-8777-2588
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Husser, Oliver
  • Sanchis, Juan|||0000-0003-0797-8709
  • Núñez, Julio|||0000-0003-1672-7119
  • Chorro, Francisco J.
  • Bodi, Vicente|||0000-0001-6425-5828
Ischemic heart disease (IHD) persists as the leading cause of death in the Western world. In recent decades, great headway has been made in reducing mortality due to IHD, based around secondary prevention. The advent of coronary revascularization techniques, first coronary artery bypass grafting (CABG) surgery in the 1960s and then percutaneous coronary intervention (PCI) in the 1970s, has represented one of the major breakthroughs in medicine during the last century. The benefit provided by these techniques, especially PCI, has been crucial in lowering mortality rates in acute coronary syndrome (ACS). However, in the setting where IHD is most prevalent, namely chronic coronary syndrome (CCS), the increase in life expectancy provided by coronary revascularization is controversial. Over more than 40 years, several clinical trials have been carried out comparing optimal medical treatment (OMT) alone with a strategy of routine coronary revascularization on top of OMT. Beyond a certain degree of symptomatic improvement and lower incidence of minor events, routine invasive management has not demonstrated a convincing effect in terms of reducing mortality in CCS. Based on the accumulated evidence more than half a century after the first revascularization procedures were used, invasive management should be considered in those patients with uncontrolled symptoms despite OMT or high-risk features related to left ventricular function, coronary anatomy, or functional assessment, taking into account the patient expectations and preferences.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Role of PCSK9 in the course of ejection fraction change after ST-segment elevation myocardial infarction, a pilot study

  • Miñana, Gema|||0000-0001-8777-2588
  • Núñez, Julio|||0000-0003-1672-7119
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Revuelta-López, Elena|||0000-0001-8962-5936
  • Ríos-Navarro, César
  • Núñez, Eduardo
  • Chorro, Francisco J.
  • López-Lereu, Maria Pilar
  • Monmeneu, Jose Vicente
  • Lupón, Josep|||0000-0002-5601-9611
  • Sanchis, Juan|||0000-0003-0797-8709
  • Bodi, Vicente|||0000-0001-6425-5828
Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a therapeutic target for reducing plasma low-density lipoprotein cholesterol. Beyond lipid control, recent findings suggest a deleterious effect of this protein in the pathogenesis of postmyocardial infarction left ventricle remodelling and heart failure-related complications. The aim of this study was to assess the relationship between circulating PCSK9 and 6 month cardiac magnetic resonance imaging-derived left ventricular ejection fraction (LVEF) after a first ST-segment elevation myocardial infarction (STEMI). We prospectively evaluated 40 patients with a first STEMI, LVEF < 50% and treated with primary percutaneous coronary intervention in which PCSK9 was measured 24 h postreperfusion. All patients underwent cardiac magnetic resonance imaging 1 week and 6 months after STEMI. Baseline characteristics were compared across median values of PCSK9. The association between PCSK9 levels and LVEF at 6 months was evaluated by analysis of covariance. The mean age of the sample was 60 ± 12 years and 33 (82.5%) were male patients. The infarct location was anterior in 27 patients (67.5%), and 9 patients (22.5%) were Killip class ≥ II. The mean 1 week and 6 month LVEF were 41 ± 7% and 48 ± 10%, respectively. The mean PCSK9 was 1.93 ± 0.38 U/mL. Testing the association between serum PCSK9 and 6 month LVEF with analysis of covariance revealed an inverse relationship (r = -0.35, P = 0.028). After multivariate adjustment, circulating PCSK9 remained significant and inversely associated with 6 month LVEF (P = 0.002). In patients with a first STEMI with reduced ejection fraction at index admission and treated with primary percutaneous coronary intervention, circulating PCSK9 was associated with lower LVEF at 6 months.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Microvascular Obstruction in ST-Segment Elevation Myocardial Infarction, Looking Back to Move Forward. Focus on CMR

  • Rios-Navarro, Cesar|||0000-0002-6405-6279
  • Marcos Garcés, Víctor|||0000-0001-5565-5547
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Núñez, Julio|||0000-0003-1672-7119
  • Bodi, Vicente|||0000-0001-6425-5828
After a myocardial infarction (MI), despite the resolution of the coronary occlusion, the deterioration of myocardial perfusion persists in a considerable number of patients. This phenomenon is known as microvascular obstruction (MVO). Initially, the focus was placed on re-establishing blood flow in the epicardial artery. Then, the observation that MVO has profound negative structural and prognostic repercussions revived interest in microcirculation. In the near future, the availability of co-adjuvant therapies (beyond timely coronary reperfusion) aimed at preventing, minimizing, and repairing MVOs and finding convincing answers to questions regarding what, when, how, and where to administer these therapies will be of utmost importance. The objective of this work is to review the state-of-the-art concepts on pathophysiology, diagnostic methods, and structural and clinical implications of MVOs in patients with ST-segment elevation MIs. Based on this knowledge we discuss previously-tested and future opportunities for the prevention and repair of MVO.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction, A cardiovascular magnetic resonance study

  • Gonzalo Calvo, David de|||0000-0003-2240-3532
  • Cediel, Germán|||0000-0001-9667-7507
  • Bär, Christian
  • Núñez, Julio|||0000-0003-1672-7119
  • Revuelta-López, Elena|||0000-0001-8962-5936
  • Gavara Doñate, Jose|||0000-0002-3483-7066
  • Ríos-Navarro, César
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
  • Bodi, Vicente|||0000-0001-6425-5828
  • Thum, Thomas|||0000-0003-4360-1511
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
Reliable noninvasive prognostic biomarkers for left ventricular (LV) remodeling in ST-segment elevation myocardial infarction (STEMI) are needed. This study aimed to evaluate a panel of circulating microRNAs (miRNAs) as biomarkers of LV remodeling using cardiovascular magnetic resonance (CMR). We prospectively evaluated patients with a first STEMI treated with primary percutaneous coronary intervention who underwent CMR imaging at 1 week and 6 months after STEMI (n = 70). miRNAs were measured using PCR-based technologies in plasma samples collected at admission. The associations between miRNAs and LV diastolic and systolic volumes, and ejection fraction at 6-months were estimated in adjusted models. Median age was 60 years, 71.4% were male. miR-1254 was significantly associated in univariate analyses. Patients in the highest tertile of miR-1254 exhibited lower values of LVEDVI and LVESVI and higher values of LVEF at 1 week. After comprehensive multivariate adjustment including clinical, CMR variables, hs-troponin-T and NT-proBNP, miRNA-1254 was associated with decreasing LVESVI (P = 0.006), and borderline negative associated with LVEDVI (P = 0.063) at 6-months. miR-1254 also exhibited a significant positive association with increasing LVEF during follow-up (P < 0.001). Plasma miRNA-1254 predicted changes in LV volumes and LVEF at 6 months after STEMI. The value of miR-1254 to inform tailored treatment selection and monitor ongoing efficacy deserves further investigation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Characterization and implications of the dynamics of eosinophils in blood and in the infarcted myocardium after coronary reperfusion

  • Rios-Navarro, Cesar|||0000-0002-6405-6279
  • Gavara Doñate, Jose|||0000-0002-3483-7066
  • Vidal, Veronica
  • Bonanad, Clara
  • Racugno, Paolo
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Miñana, Gema|||0000-0001-8777-2588
  • Husser, Oliver
  • Oltra, Ricardo
  • Núñez, Julio|||0000-0003-1672-7119
  • Chorro, Francisco J.
  • Bodi, Vicente|||0000-0001-6425-5828
  • Ruiz-Sauri, Amparo
We characterized the dynamics of eosinophils in blood and in the infarcted myocardium in patients and in a swine model of reperfused myocardial infarction (MI). The association of eosinophil dynamics with various outcomes was assessed. Serial eosinophil count and pre-discharge cardiac magnetic resonance were carried out in a prospective series of 620 patients with a first ST-elevation MI. In a swine model of reperfused MI, the dynamics of circulating eosinophils and their presence in the infarcted myocardium were determined. In autopsies from chronic MI patients, eosinophils were quantified. Patient eosinophil count sharply decreased 12h post-reperfusion compared to arrival. A lower minimum eosinophil count was associated with more extensive edema, microvascular obstruction, and infarct size as measured by cardiac magnetic resonance, and also with a higher rate of cardiac events (death, re-infarction, or heart failure) during follow-up. In the experimental model, eosinophil count boosted during ischemia and dropped back immediately post-reperfusion. Myocardial samples revealed progressive eosinophil migration into the infarcted myocardium, especially areas with microvascular obstruction. Markers of eosinophil maturation and survival (interleukin-5), degranulation (eosinophil cationic protein) and migration (eotoxin-1) were detected in the blood of patients, and in porcine myocardium. Eosinophil infiltration was detected in autopsies from chronic MI patients. Eosinopenia post-MI was associated with an impaired cardiac structure and adverse events. The decay in circulating eosinophils soon after reperfusion mirrors their migration into the infarcted myocardium, as reflected by their presence in heart samples from swine and patients. Further studies are needed to understanding this unexplored pathway and its therapeutic implications.